Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

int med 2024 > Acute coronary syndrome > Flashcards

Acute coronary syndrome Flashcards

1
Q

what is Acute coronary syndrome

A

clinical manifestation of myocardial infarct and commonly the default working diagnosis in patients with new onset chest pain suspected to be of cardiac ischaemic origin
divided into unstable angina, NSTEMI and STEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define unstable angina

A

acute myocardial ischemia that is not severe enough to cause detectable quantities of myocardial injury biomarkers or ST segment elevations on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define NSTEMI

A

acute myocardial ischaemia that is severe enough to cause detectable quantities of myocardial injury biomarkers without ST segment elevations on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define STEMI

A

acute myocardial ischaemia that is severe enoiugh to cause ST segment elevations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cardinal sympotms of MI

A

diaphoresis
sense of impending doom
nausea and vomiting
dyspnoea
restrosternal pain radiating to the left side of the body (arm, shoulder, neck and epigastrium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

non specific signs of MI esp. in women

A

dizziness
lightheadedness, syncope
fatigue, exhaustion
jaw, neck, upper back pain
palpitations
epigastric discomfort or pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical presentation of angina type pain

A

occuring at rest with minimal exertion, not relieved by rest or nitroglycerin
new onset
severe, persistant, worsening (crescendo angina)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

autonomic symptoms

A

diaphoresis, syncope, palpitations, nausea and/or vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pathophysiology of unstable angina

A

partial occlusion of coronary vessel
decreased blood supply
ischaemic symptoms without infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathophysiology of NSTEMI

A

classicially due to partial occlusion of a coronary artery
affects the inner layer of the heart (subendocardial infarction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pathophysiology of STEMI

A

classically due to complete occlusion of coronary artery
affects the full thickness of the myocardium (transmural infarction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cardaic troponins

A

elevated in NSTEMI and STEMI within 1-6 hours
may initially be undetectable in patients who present early after symptom onset, especially if conventional rather than high sensitivity troponin assays are used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ECG findings for unstable angina and NSTEMI

A

no ST elevations
normal or non-specific eg. ST depression, loss of R wave, T wave inversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ECG findings for STEMI

A

ST elevations in two contiguous leads or new LBBB with strong clinical suspicion of myocardial ischaemia
ST elevations can be masked by LBBB. however the presence of a new of presumably new LBBB in a patient with ACS is not always an ndication for PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

initial management for the patient presenting with acute coronary syndrome

A

direct to resus
monitor ECG and O2
take obs (bilateral BP if dissectionn is being considered)
takes bloods - FBC, UEC, BSL, trops (senior doctor may add d-dimer if indicated)
CXR
aspirin unless already given or contrindicated
oxygen only if hypoxic <93%
take ECG for urgent review by senior
GTN (SL and then IV if required)
other analgesia eg. titrated morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management for unstable angina and NSTEMI

A

invasive management depends on risk stratification
aspirin 300mg and tiicagrelor load 180mg plus 90mg bd
statins
beta blockers
ACEIs
pain management (opoiods, nitrates, titratd morphine)
do an EDACS score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Management for STEMI

A

immidiate revascularisation
adjunctive therapy similar to NSTEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

can subtypes of ACS be differentaited based on clinical presentation

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

the type of MI is determined based on

A

ECG findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

unstable angina is differentiated from MI by

A

positive troponins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

clinical triad for right ventricular infarction

A

hypotension
elevated JVP
clear lung feilds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

initial triage based on ECG findings

A

ST elevations present: start management of STEMI with immediate revascularisation therapy, preferably PCI

23
Q

transthoracic echocardography

A

generally not necessary
should not delay reperfusion therapy
may be helpful study in patients with atypical symptoms or if the diagnosis is unclear

24
Q

findings in transthoracic echcardioraphy

A

wall motion abnormalities
decreased LV function
signs of different conditions that cause chest pain

25
Q

reperfusion therapy

A

PCI or thrombinolysis

26
Q

STEMI treatment of choice

A

PCI vs. fibrinolysis
aim for PCI within 90 minutes of first medical contact
consider IV fibrinolytics if:
- PCI cant be performed within 120 minutes
- there are no contraindications to fibrinolytics for STEMI

27
Q

ECG changes in STEMI

A

significant ST elevation in two contiguous leads
findings may change over time
hyperacute T waves can present without ST elevations in the very early stages of ischaemia
If inferior MI is suspected, investigate for signs of right ventricular involvement

28
Q

when are Q waves pathological

A

duration >0.04 seconds
amplitude >1/4 of the R waves
any Q wave in leads V1-3

29
Q

ECG changes in chronic stage

A

permanent scarring
persistent, broad deep Q waves
often incomplete recovery of R waves
permanent T-wave inversion is possible

30
Q

the EDACS score

A

risk assessment for patients presenting to the ED with chest pain

31
Q

procedure for PCI

A

coronary angiography with PCI ie. baloon dilatation with stent implantation

32
Q

Fibrinolytic therapy is indicated if

A

PCI cannot be performed within 120 minutes of FMC
no contraindications to fibrinolysis are present

33
Q

regimens for fibrinolysis

A

Tenecteplase
Alteplase
Reteplase
Streptokinase

34
Q

absolute contraindications for fibrinolysis in STEMI

A

weigh risks and benefits carefully in individual patients
active bleeding (not including menses)
bleeding diathesis/known coagulopathy
any prior intracranial bleeding
intracranial or intraspinal surgery within the past 2 months
serious head trauma within the past 3 months
severe hypertension unresponsive to emergency therapy
intracranial conditions increasing risk of bleeding eg. AV malformation
suspected aortic dissection
intracranial malignancy
for streptokinase: previous exposure within the last 6 months (highly antigenic)

35
Q

streptokinase is contraindicated when

A

there has been previous exposure to streptokinase within the last 6 months

36
Q

antiplatelet therapy and anticoagulation in STEMI if undergoing PCI

A

DAPT: Aspirin and
ADP receptor inhibitor (Prasugral or ticagrelor is preferred, otherwise clopidogrel)
anticoagulation: unfractionated heparin, bivalirudin
consider adjunctive use of glycoprotein inhibitor

37
Q

antiplatelet therapy and anticoagulation in STEMI if NOT undergoing PCI

A

aspirin and clopidogrel (DAPT)
one of: unfractionated heparin, enoxaparin, fondaparinux (anticogulant)
glycoprotein not routinely recommended

38
Q

for patients presenting more than 12 hours after symptom onset

A

myocardial infarction may already be complete, but still consider PCI/thrombolytic therapy if
- ongoing ischaema (persistant pain, dynamic changes on ECG)
- viable myocaardium (preservation of R waves)
- major complications ( cardiogenic shock, heart failure, malignant arrythmia)

39
Q

when is PCI preferred over thrombolytic therapy

A

PCI is mor beneficial over thrombolytic therapy in reducing mortality, recurrent MI and stoke.
the benefit of PCI over thrombinolysis increases aas time between symptom onset and patient presentation increases

40
Q

if thrombolytic therapy fails

A

if the patient is at a centre where PCI is not available and thrombolytic therapy is either contraindicated or has failed, promptly transfer the patient to a centre where PCI is availble

41
Q

how do you know if thrombolytic therapy has failed

A

50% or less ST resolution after 60 to 90 minutes
or
continued haemodynamic instability

41
Q

what to do if thrombolytic therapy succeeds

A

arrange transfer to a centre where percutaneous coronary intervention is available with a plan for coronary angiography within 24 hours

42
Q

long term medication for STEMI

A

antiplatelet
statin
ACEI/ARB
beta blocker

43
Q

are fibrinolytics indicated in NSTEMI

A

no

44
Q

how to risk stratify NSTEMIs

A

use EDACS score / GRACE score
ECG changes?
ongoing ischaemic-like chest pain
syncope, systolic BP<90 not due to GTN, haemodynamic instability, signs and symptoms of heart failure, signs and symptoms of heart failure/pulomnnary oedema, recent PCI pr prior CABG, sustainedarrythmia

45
Q

invasive strategy for NSTEMI for very high to intermediate risk patients

A

within 2 hours for very high risk
within 24 hours for high risk

46
Q

ischaemia guided strategy for NSTEMI

A

for stable, low risk patients
non invasive cardiac stress testing eg. exercise ECG, stress echo) to evaluate need for coronary angiography

47
Q

antiplatelet therapy and anticoagulation for NSTEMI

A

DAPT: aspirin and either Ticagralor or clopidogrel (ADP receptor inhibitors)
anticoagulation: enoxaparin, unfractionated heparin, fondaparinux or bilivardin only in invasive strategy
consider glyoprotein inhibitor for intermediate/high risk patients with early invasive strategy

48
Q

monitoring during ACS

A

continuous cardiac monitoring
serial 12 lead ECG every 15-30 minutes
serial serum troponin measurement every 1-6 hours

49
Q

adjunct medical therapy in ACS

A

nitrates
beta blockers
opioids
ACE inhibitors/ARBs
aldosterone agonists
high intensity statin

50
Q

acronym for MI management

A

MONA BASH

Morphine
Oxygen
Nitroglycerin
Antiplatelets (aspirin + ADP receptor inhibitor)
beta blockers
ACE inhibitors
Statins
Heparin

51
Q

oxygen therapy should be used for patients with

A

cyanosis
severe dyspnoea
SpO2 <93%

52
Q

fluid management

A

IV fluids: consider for inferior MI causing RV dysfunction, because increasing preload optimises left and right ventricular filling and reduces haemodynamic instaability
loop diuretic eg. furosemide: consider for patients with pulmonary oedema, acute heart failure

53
Q
A

int med 2024 (47 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions